ODX.L Share News (ODX)

STOCKS NEWS EUROPE-UK small caps lag AIM-listed shares

Junior-listed AIM shares rise 0.3 percent, outperforming the FTSE Small Cap index, down 0.3 percent, the mid-caps, down 0.7 percent, and the blue chips, which fall 0.6 percent. Troubled Czech coalminer New World Resources drops 6.9 percent, the top small cap faller, after posting a record 4

Omega Diagnostics Completes CD4 Technology Transfer Project

LONDON (Alliance News) - Omega Diagnostics Group PLC said Thursday that it had completed its CD4 technology transfer project, having successfully completed a three-batch validation of its manufacturing protocol. The medical diagnostics company has been undertaking a number of experiments to

Omega Diagnostics Confident For Next Year But Cautious On This One

STOCKS NEWS EUROPE-UK small caps rise, lagging blue-chips

The FTSE Small Caps Index edges up by 0.2 percent in early session trading, slightly lagging a 0.4 percent advance on the blue-chip FTSE 100 index and underperforming a 0.6 percent rise on the FTSE 250 mid-caps index . The junior-listed FTSE AIM All Share Index slips 0.1 percent. Paw

AIM IN BRIEF: Albemarle & Bond Sees No Signs Of Recovery

Omega Diagnostics Expects To Complete CD4 Technology Transfer By End December

Omega Diagnostics Expects Full-Year Revenues Of GBP5.6 Million

Omega hurt by weak UK, European markets

Medical diagnostics firm Omega said full year profit tumbled 22 per cent following a slowdown in growth in European markets. Adjusted profit before tax fell to £0.78m in the year to the end of March from £1.0m in 2012. Annual turnover was little changed at £11.3m compared to £11.1m previously. Gr

Omega Diagnostics raises funds for research and development

Medical company Omega Diagnostics Group has raised four million pounds through the placement of over 23m shares which will be used to fund the development of new products. The company, focused on developing diagnostics for allergies, food intolerances and infectious diseases, said it intends to use

Omega Diagnostics awarded grant for HIV test

Omega Diagnostics has been awarded a grant of up to 150,000 pounds from Scottish Enterprise to help scale up manufacturing facilities for the company's new CD4 test for monitoring HIV positive patients. The facility will be located at the company's headquarters in Alva, Central Scotland and the gr

Omega Diagnostics unveils strong year

Medical diagnostics group Omega Diagnostics posted a strong set of full year results which saw turnover rise 41 per cent and gross profit leap 49 per cent. Pre-tax profits came in at £0.48m (2011: £0.12m) on revenues of £11.1m, compared with £7.9m the previous year. Earning per share rose from 0.1

Small caps round-up: Omega Diagnostics, Oxford Biomedica, i-design ...

The cash-point marketing company i-design said that revenues for the first half of its current financial year will be ahead of the same period of 2011. The group creates advertising solutions for banks and third parties through cash-point screens. A new contract with a Canadian bank has boosted turn

Omega Diagnostics grows profit by 53%

Omega Diagnostics has pushed up its interim profit and there will be more to come when it completes the acquisition of a Germany-based allergy testing business. Revenues grew from £2.87m to £3.3m in the six months to September 2010, while underlying profit jumped from £263,000 to £403,000. That pro

Small caps round-up: Judges Scientific, Media Corp, Omeda Diagnostics...

Scientific instruments designer Judges Scientific revealed that trading has continued to be "favourable" and adjusted earnings in respect of 2010 are likely to exceed current market expectations. Additionally, gas purifier and calibration equipment provider Sircal Instruments, acquired in March, has

Small caps round-up: Tri-Star

Mining company Tri-Star has entered into an agreement with a Turkish contractor to undertake a 17-hole diamond drilling programme of the company's Goynuk antimony mine. Shares in Omega Diagnostics, which specialises in the diagnosis of diseases such as syphilis and TB, soared 16% after it reporte